Brain tumors: MR imaging with gadolinium-DTPA.

R. Félix, W. Schörner, Michael Laniado, +4

Radiology

EngineeringPet-mriMagnetic ResonanceBrain LesionGlioma +15

Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.

Jens Haustein, Michael Laniado, H. P. Niendorf, +7

Radiology

Magnetic ResonancePharmacotherapyBrain LesionMagnetic Resonance ImagingNeuro-oncology +21

Time-dependent changes in image contrast in brain tumors after gadolinium-DTPA.

W. Schörner, Michael Laniado, H.P. Niendorf, +2

PubMed

EngineeringImaging AgentBrain LesionMagnetic Resonance ImagingNeuro-oncology +14

Bolus geometry and dynamics after intravenous contrast medium injection.

CD Claussen, D. Banzer, C Pfretzschner, +2

Radiology

Computed TomographyEngineeringVascular ImageMedical ImagingBiomedical Imaging +12

Graves ophthalmopathy: MR imaging of the orbits.

Norbert Hosten, B. Sander, M. Cordes, +3

Radiology

Ocular DiseaseOphthalmic PathologyOphthalmologyMedical ImagingMagnetic Resonance +10

Dose administration of gadolinium-DTPA in MR imaging of intracranial tumors.

H. P. Niendorf, Michael Laniado, Willi Semmler, +2

PubMed

EngineeringPet-mriTumor VisualizationWhole BloodHigh-grade Gliomas +14

Gadolinium-DTPA in MR imaging of glioblastomas and intracranial metastases.

Claus D. Claussen, Michael Laniado, W. Schörner, +4

PubMed

EngineeringPet-mriMagnetic ResonanceHigh-grade GliomasGlioma +16

Acute fracture of the femoral neck: assessment of femoral head perfusion with gadopentetate dimeglumine-enhanced MR imaging.

Philipp Lang, M. Mauz, W. Schörner, +7

American Journal of Roentgenology

Administration of gadopentetate dimeglumine in MR imaging of intracranial tumors: dosage and field strength.

Jens Haustein, Michael Laniado, Hans-Peter Niendorf, +4

PubMed

First use of GdDTPA/dimeglumine in man.

Michael Laniado, Hanns‐Joachim Weinmann, W. Schörner, +2

PubMed

UrologyLow ToxicityGd-dtpa ComplexMedicinePhysiology +10